Ayrton Capital’s Envoy Medical COCH Stock Holding History

Ayrton Capital’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-82,900	Closed	-$831K	–	88
2022 Q4	$831K	Hold	82,900	–	–	2.27%	18
2022 Q3	$814K	Hold	82,900	–	–	1.43%	25
2022 Q2	$812K	Hold	82,900	–	–	1.32%	24
2022 Q1	$810K	Hold	82,900	–	–	1.05%	36
2021 Q4	$807K	Buy	+82,900	New	+$809K	0.76%	41

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Ayrton Capital's COCH Position: Q1 2023 in Review

Ayrton Capital sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 82,900 shares — an estimated $831K sold.

Ayrton Capital first reported a position in COCH in Q4 2021 and held it in 5 quarters. The position peaked at $831K in Q4 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Ayrton Capital reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Ayrton Capital sold 82,900 Envoy Medical shares in Q1 2023, an estimated $831K.
Ayrton Capital first reported a position in Envoy Medical in Q4 2021 and held it in 5 quarters.
Ayrton Capital's Envoy Medical position peaked at $831K in Q4 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Ayrton Capital's 13F filing for Q1 2023, filed 12 May 2023.